Dose dependency of furosemide-induced sodium excretion
- PMID: 2703969
Dose dependency of furosemide-induced sodium excretion
Abstract
Intravenous furosemide doses ranging from 5 to 120 mg were given to healthy young volunteers with and without individualized active rehydration with a sodium chloride solution. Sodium excretion rates and fractional sodium excretions (FENa) percentages were correlated significantly with dose and with urinary excretion rates of furosemide. The ED50 was below 5 mg and no additional natriuretic effect was seen above 40 mg. The efficiency (FENa percentage per microgram of furosemide excreted per minute during a certain clearance period) was dependent on hydration and on time. For the period 15 to 30 min a significant linear relationship between furosemide dose and the reciprocal of the efficiency indicated a higher efficiency for lower doses and a theoretical maximal value of FENa of 0.4% per micrograms of furosemide excreted per minute. A relative value for a dose-dependent efficiency reduction was calculated for each dose. The ED50 for dose-dependent efficiency reduction was about 12 mg i.v. Simultaneous measurements of lithium clearance indicated a proximal site of action for furosemide which was saturated at furosemide excretion rates above 50 micrograms/minute. For the major, distal, site of action no maximal value was demonstrated. It is concluded that a wanted balance between a strong natriuretic effect and weak sodium retaining mechanism not necessarily is achieved by a high dose and that information concerning that problem must be obtained from studies in relevant patient groups.
Similar articles
-
Dose dependence of proximal and distal tubular effects of furosemide in conscious rats.J Pharmacol Exp Ther. 1987 Jun;241(3):987-93. J Pharmacol Exp Ther. 1987. PMID: 3598915
-
Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats.J Pharmacol Exp Ther. 1995 Sep;274(3):1348-54. J Pharmacol Exp Ther. 1995. PMID: 7562507
-
Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.Hepatology. 2000 Jun;31(6):1224-30. doi: 10.1053/jhep.2000.7518. Hepatology. 2000. PMID: 10827146
-
Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.Dan Med Bull. 1998 Jun;45(3):282-97. Dan Med Bull. 1998. PMID: 9675540 Review.
-
Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.Dan Med Bull. 1997 Apr;44(2):191-207. Dan Med Bull. 1997. PMID: 9151012 Review.
Cited by
-
Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial.PLoS One. 2015 Sep 14;10(9):e0137163. doi: 10.1371/journal.pone.0137163. eCollection 2015. PLoS One. 2015. PMID: 26367377 Free PMC article. Clinical Trial.
-
Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).Clin Pharmacokinet. 1990 Jun;18(6):460-71. doi: 10.2165/00003088-199018060-00003. Clin Pharmacokinet. 1990. PMID: 2191821 Review.
-
Why maximum tolerated dose?Br J Clin Pharmacol. 2019 Oct;85(10):2213-2217. doi: 10.1111/bcp.14032. Epub 2019 Jul 22. Br J Clin Pharmacol. 2019. PMID: 31219196 Free PMC article. Review.
-
Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50.Br J Clin Pharmacol. 2019 Oct;85(10):2218-2227. doi: 10.1111/bcp.14033. Epub 2019 Aug 19. Br J Clin Pharmacol. 2019. PMID: 31219198 Free PMC article. Review.
-
Analysis of the natriuretic action of a loop diuretic, piretanide, in man.Br J Clin Pharmacol. 1991 Apr;31(4):463-9. doi: 10.1111/j.1365-2125.1991.tb05563.x. Br J Clin Pharmacol. 1991. PMID: 2049256 Free PMC article.